BG102678A - 1,4-dihydropyridine compounds as bradykinin antagonists - Google Patents

1,4-dihydropyridine compounds as bradykinin antagonists

Info

Publication number
BG102678A
BG102678A BG102678A BG10267898A BG102678A BG 102678 A BG102678 A BG 102678A BG 102678 A BG102678 A BG 102678A BG 10267898 A BG10267898 A BG 10267898A BG 102678 A BG102678 A BG 102678A
Authority
BG
Bulgaria
Prior art keywords
bradykinin
compounds
octyl
alkyl
bradykinin antagonists
Prior art date
Application number
BG102678A
Other languages
Bulgarian (bg)
English (en)
Inventor
Takafumi Ikeda
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of BG102678A publication Critical patent/BG102678A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BG102678A 1996-02-19 1998-08-10 1,4-dihydropyridine compounds as bradykinin antagonists BG102678A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB9600132 1996-02-19
PCT/IB1997/000058 WO1997030048A1 (en) 1996-02-19 1997-01-27 1,4-dihydropyridine compounds as bradykinin antagonists

Publications (1)

Publication Number Publication Date
BG102678A true BG102678A (en) 1999-04-30

Family

ID=11004406

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102678A BG102678A (en) 1996-02-19 1998-08-10 1,4-dihydropyridine compounds as bradykinin antagonists

Country Status (34)

Country Link
US (1) US6131226A (xx)
EP (1) EP0882044B1 (xx)
JP (1) JP3167335B2 (xx)
KR (1) KR19990082678A (xx)
CN (1) CN1211251A (xx)
AR (1) AR005841A1 (xx)
AT (1) ATE220676T1 (xx)
AU (1) AU1396497A (xx)
BG (1) BG102678A (xx)
BR (1) BR9707568A (xx)
CA (1) CA2245857C (xx)
CO (1) CO4650041A1 (xx)
CZ (1) CZ258698A3 (xx)
DE (1) DE69714019T2 (xx)
DK (1) DK0882044T3 (xx)
ES (1) ES2177921T3 (xx)
HN (1) HN1997000013A (xx)
HR (1) HRP970094A2 (xx)
HU (1) HUP9902810A3 (xx)
ID (1) ID16434A (xx)
IL (1) IL124867A0 (xx)
IS (1) IS4783A (xx)
MA (1) MA26419A1 (xx)
NO (1) NO983776L (xx)
NZ (1) NZ325455A (xx)
OA (1) OA10712A (xx)
PE (1) PE36298A1 (xx)
PL (1) PL328514A1 (xx)
PT (1) PT882044E (xx)
SI (1) SI0882044T1 (xx)
TN (1) TNSN97037A1 (xx)
TR (1) TR199801593T2 (xx)
WO (1) WO1997030048A1 (xx)
ZA (1) ZA971357B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11106375A (ja) * 1997-08-18 1999-04-20 Pfizer Pharmaceut Inc ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物
US6653313B2 (en) * 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
GB0427281D0 (en) * 2004-12-14 2005-01-12 3M Innovative Properties Co Methods of providing medicinal metal components having through holes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120750A (en) * 1989-01-17 1992-06-09 Synphar Laboratories, Inc. Generation of 1,4-dihydropyridine derivatives
WO1996006083A1 (en) * 1994-08-24 1996-02-29 Pfizer Pharmaceuticals Inc. 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists
MX9701245A (es) * 1996-02-19 1998-04-30 Pfizer Compuestos de 1,4 dihidropiridina.

Also Published As

Publication number Publication date
EP0882044B1 (en) 2002-07-17
JPH11507949A (ja) 1999-07-13
SI0882044T1 (en) 2002-10-31
PE36298A1 (es) 1998-07-18
IL124867A0 (en) 1999-01-26
NO983776D0 (no) 1998-08-18
HUP9902810A2 (hu) 2000-05-28
TNSN97037A1 (fr) 2005-03-15
DK0882044T3 (da) 2002-09-02
JP3167335B2 (ja) 2001-05-21
NZ325455A (en) 1999-07-29
KR19990082678A (ko) 1999-11-25
EP0882044A1 (en) 1998-12-09
PT882044E (pt) 2002-11-29
CZ258698A3 (cs) 1999-06-16
HN1997000013A (es) 1997-06-26
ZA971357B (en) 1998-08-18
AU1396497A (en) 1997-09-02
OA10712A (en) 2001-06-04
CA2245857C (en) 2002-10-01
DE69714019D1 (de) 2002-08-22
MA26419A1 (fr) 2004-12-20
CA2245857A1 (en) 1997-08-21
NO983776L (no) 1998-08-18
TR199801593T2 (xx) 1999-12-21
HUP9902810A3 (en) 2000-09-28
BR9707568A (pt) 1999-07-27
IS4783A (is) 1998-06-25
HRP970094A2 (en) 1998-06-30
PL328514A1 (en) 1999-02-01
CN1211251A (zh) 1999-03-17
AR005841A1 (es) 1999-07-14
WO1997030048A1 (en) 1997-08-21
ID16434A (id) 1997-09-25
ES2177921T3 (es) 2002-12-16
DE69714019T2 (de) 2002-11-14
CO4650041A1 (es) 1998-09-03
ATE220676T1 (de) 2002-08-15
US6131226A (en) 2000-10-17

Similar Documents

Publication Publication Date Title
SG158731A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
DE69721766D1 (de) Neue arzneiformulierung
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
BG102202A (en) Enantiomer and ipratropiumbromide with extended effect
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
BR0110487A (pt) Composição farmacêutica e método de tratamento de doenças de disfunção cognitiva em um mamìfero
MX9501848A (es) Nuevos compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
BR9714677A (pt) &#34;enantiÈmeros 3-piridila e seu uso como analgésicos&#34;
DE4394931T1 (de) Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DK0837935T3 (da) Den 3&#39;-ikke-translaterede region af det humane prohibitin-gen
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
ATE83376T1 (de) Chinolinylaether tetrazole als mittel zur behandlung von hyperempfindlichen krankheiten.
ATE82127T1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
BG101220A (en) N-substituted 3-azabicyclo (93.2.0) heptane derivatives,their preparation and use
BG102678A (en) 1,4-dihydropyridine compounds as bradykinin antagonists
TR199901385T2 (xx) Piperidin t�revleri.
EP0769299A4 (en) AGAINST ALLERGIC DISEASES IN THE NOSE
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
DE69429447T2 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
UA9703A (uk) Антипротеіназний засіб
WO1999019324A3 (en) Antipsychotic substituted piperidine derivatives
HUP9903490A3 (en) Substituted 4-(1h-benzimidazol-2-yl)[1,4]diazepanen derivatives useful for the treatment of allergic diseases, preparation and use thereof
DE69429538D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen